Related Experiment Video
Updated: Oct 6, 2025

In Vivo Forward Genetic Screen to Identify Novel Neuroprotective Genes in Drosophila melanogaster
Published on: July 11, 2019
Transposable element activation promotes neurodegeneration in a Drosophila model of Huntington's disease
Assunta Maria Casale1, Francesco Liguori1, Federico Ansaloni2
1Department of Biology and Biotechnology "C. Darwin", Sapienza University of Rome, Rome, Italy.
Insights
This study reveals that increased transposable element (TE) activity contributes to neurotoxicity in Huntington's disease (HD) models. Inhibiting TE mobilization offers a promising therapeutic strategy for this genetic disorder.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is a fatal neurodegenerative disorder caused by CAG repeat expansion in the Huntingtin gene.
- Currently, no effective treatments exist for HD, necessitating the identification of novel therapeutic targets.
- Transposable elements (TEs), or 'jumping genes,' are DNA sequences capable of changing their genomic position and are implicated in neurological diseases.
Purpose of the Study:
- To investigate the role of TE activity in Huntington's disease pathogenesis.
- To explore the potential of inhibiting TE mobilization as a therapeutic strategy for HD.
Main Methods:
- Utilized a *Drosophila melanogaster* model of Huntington's disease.
- Assessed TE expression and mobilization in the HD model.
- Administered Reverse Transcriptase inhibitors to block TE mobilization.
- Evaluated the effects of TE inhibition on neurodegeneration, genome instability, and lifespan.
Main Results:
- TE expression and mobilization were significantly increased in the *Drosophila* HD model.
- Inhibition of TE mobilization using Reverse Transcriptase inhibitors rescued polyglutamine-dependent eye neurodegeneration.
- TE inhibition also reduced genome instability in larval brains and extended fly lifespan.
- These findings demonstrate a link between TE activation and polyQ-induced neurotoxicity.
Conclusions:
- TE activation is implicated in the neurotoxicity associated with Huntington's disease.
- Inhibiting TE mobilization presents a potential novel therapeutic avenue for treating HD.
- Targeting TE activity could offer a new strategy to combat polyglutamine-induced neurodegeneration.
Abstract:
Huntington's disease (HD) is an autosomal dominant disorder with progressive motor dysfunction and cognitive decline. The disease is caused by a CAG repeat expansion in the IT15 gene, which elongates a polyglutamine stretch of the HD protein, Huntingtin. No therapeutic treatments are available, and new pharmacological targets are needed. Retrotransposons are transposable elements (TEs) that represent 40% and 30% of the human and Drosophila genomes and replicate through an RNA intermediate. Mounting evidence suggests that mammalian TEs are active during neurogenesis and may be involved in diseases of the nervous system. Here we show that TE expression and mobilization are increased in a Drosophila melanogaster HD model. By inhibiting TE mobilization with Reverse Transcriptase inhibitors, polyQ-dependent eye neurodegeneration and genome instability in larval brains are rescued and fly lifespan is increased. These results suggest that TE activation may be involved in polyQ-induced neurotoxicity and a potential pharmacological target.
More Related Videos
Related Concept Videos
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Non-LTR Retrotransposons
Overview of Transposition and Recombination

